SCHEMBL6637594

SCHEMBL6637594

CC(C)(N)c1ccc(Cl)s1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.38
PPARA Q07869 1/20 0.37
TSHR P16473 2/20 0.34
DAO P14920 1/20 0.33
SLC6A2 P23975 1/20 0.32
HTR2A P28223 1/20 0.32
SLC6A4 P31645 1/20 0.32
HRH1 P35367 1/20 0.32
HTR2B P41595 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PDE2A O00408 1/20 0.32
AR P10275 2/20 0.32
HTT P42858 1/20 0.31
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30
LMNA P02545 1/20 0.30
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803424 0.82 KMT2A (0.38) F2PPARATSHRDAOAR
SCHEMBL24637672 0.81 LMNA (0.36) TSHRSLC6A2PDE2ALMNA
SCHEMBL19413743 0.78 TSHR (0.38) F2PPARATSHRDAOAR
SCHEMBL6990461 0.78 TAAR1 (0.39) F2PPARATSHRSLC6A2HTR2A
SCHEMBL12691851 0.75 ALDH1A1 (0.36) F2PPARATSHRDAOAR
SCHEMBL9037642 0.74 F2 (0.48) F2PPARATSHRDAOHTT
SCHEMBL21841894 0.74 MAPK1 (0.39) TSHRPDE2ALMNA
SCHEMBL9036699 0.73 AR (0.38) PPARATSHRAR
SCHEMBL24346237 0.73 PPARA (0.37) F2PPARATSHRDAOAR
SCHEMBL353045 0.72 NPC1 (0.34) TSHRDAOLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758897-B1 COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES AVENTIS PHARM PROD INC (US) 2004-02-25 EP disclosed
US-6392049-B1 NITRATION USING NITRIC ACID AVENTIS PHARMACEUTICALS INC. 2002-05-21 US disclosed
US-6307054-B1 HEATING A 5-CARBOXY-2,4-DIHYROXYPYRIDINE AND PHOSPHORIC ACID WHERE THE RATIO OF PHOSPHORIC ACID TO WATER IS NOT LESS THAN ABOUT 27 TO 1 WEIGHT %. AVENTIS PHARMACEUTICALS PRODUCTS INC. 2001-10-23 US disclosed
EP-1006115-A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 2000-06-07 EP disclosed
EP-0909270-A1 PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-04-21 EP disclosed
EP-0909270-A4 1999-04-21 EP disclosed
CN-1038682-C Cyclic amide compounds, process for their production and their use as herbicides ISHIHARA SANGYO KAISHA (JP) 1998-06-10 CN disclosed
US-5736554-A TREATING AND/OR PREVENTING CARDIOVASCULAR DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-04-07 US disclosed
EP-0758897-A4 COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES RHONE POULENC RORER PHARMA (US) 1997-11-19 EP disclosed
US-5652366-A ADENOSINE AGONISTS; HYPOTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTILIPOLYTIC AGENTS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-29 US disclosed
WO-1997024327-A1 PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-10 WO disclosed
EP-0758897-A1 COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-02-26 EP disclosed
US-5561134-A ADENOSINE DERIVATIVES RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-10-01 US disclosed
WO-1995028160-A1 COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-10-26 WO disclosed
US-5364862-A Adenosine derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-11-15 US disclosed